The Importance of Stereochemistry in 5-HT7R Modulation─A Case Study of Hydantoin Derivatives
Open Access
- 21 October 2024
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Chemical Neuroscience
- Vol. 15 (21) , 3884-3900
Abstract
Serotonin 5-HT7 receptor (5-HT7R), one of the most recently discovered members of the serotonergic system, has become a promising target in the search for central nervous system disorders. Despite the number of preclinical results, none of the selective 5-HT7R agents has been approved; therefore, the clinical significance of this protein has not been confirmed yet. Recently, we described very promising, selective, and highly potent hydantoin-derived 5-HT7R antagonists with confirmed antidepressant activity in vivo and a very good ADMET profile; however, they have been tested in behavioral studies as racemates. In this work, the synthesis of optically pure hydantoin-derived 5-HT7R agents using cost-effective, classical methods has been presented for the first time. X-ray crystallographic analysis confirmed the absolute configuration on both stereogenic centers and allowed for the elucidation of the mechanism of introduction of epichlorohydrin into the hydantoin N3-position. The radioligand binding results showed a clear configuration preference for 5-HT7R affinity. The molecular modeling results further indicated the key interaction responsible for lower affinity (with amino acid I3 × 29). Finally, the comparison of the antidepressant and anxiolytic effects of racemates versus stereoisomers suggests an influence of additional, apart from the action on 5HT7R, factors responsible for the activity in vivo, which is worthy of deeper insight within further studies.Keywords
Funding Information
- Uniwersytet Jagielloński w Krakowie (N42/DBS/000103, N42/DBS/000337)
This publication has 52 references indexed in Scilit:
- Targeting the brain 5-HT7 receptor to prevent hypomyelination in a rodent model of perinatal white matter injuriesJournal of Neural Transmission, 2022
- Serotonin 5-HT7 receptor is a biomarker poor prognostic factor and induces proliferation of triple-negative breast cancer cells through FOXM1Breast Cancer, 2022
- Advances and challenges in the pharmacokinetics and bioanalysis of chiral drugsChirality, 2022
- Design and discovery of a high affinity, selective and β-arrestin biased 5-HT7 receptor agonistMedicinal Chemistry Research, 2021
- Discovery of Nonracemic Amisulpride to Maximize Benefit/Risk of 5‐HT7 and D2 Receptor Antagonism for the Treatment of Mood DisordersClinical Pharmacology & Therapeutics, 2021
- 5-HT7 receptors as a new target for prostate cancer physiopathology and treatment: an experimental study on PC-3 cells and FFPE tissuesNaunyn-Schmiedeberg's Archives of Pharmacology, 2021
- Analysis, fate and toxicity of chiral non-steroidal anti-inflammatory drugs in wastewaters and the environment: a reviewEnvironmental Chemistry Letters, 2020
- The serotonin 5-HT7 receptors: two decades of researchExperimental Brain Research, 2013
- Evaluation of a rapid technique for detecting minor tranquilizersNeuropharmacology, 1971
- Specification of Molecular ChiralityAngewandte Chemie International Edition, 1966